CFO
INSP icon

CVA Family Office’s Inspire Medical Systems INSP Stock Holding History

CVA Family Office’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$478 – 1364
2025
Q1 		$478 Hold
3
– – ﹤0.01% 1297
2024
Q4 		$556 Hold
3
– – ﹤0.01% 1203
2024
Q3 		$633 Buy
+3
New +$521 ﹤0.01% 1142

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CVA Family Office's INSP Position: Q2 2025 in Review

CVA Family Office sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 3 shares — an estimated $478 sold.

CVA Family Office first reported a position in INSP in Q3 2024 and held it in 3 quarters. The position peaked at $633 in Q3 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • CVA Family Office reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • CVA Family Office sold 3 Inspire Medical Systems shares in Q2 2025, an estimated $478.
  • CVA Family Office first reported a position in Inspire Medical Systems in Q3 2024 and held it in 3 quarters.
  • CVA Family Office's Inspire Medical Systems position peaked at $633 in Q3 2024.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on CVA Family Office's 13F filing for Q2 2025, filed 31 Jul 2025.